FR-229934 |
| Catalog No.GC62977 |
FR-229934는 특허 WO2019130052A1에서 추출한 PDE V 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 799841-02-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
[1]. PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1.
Review for FR-229934
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for FR-229934
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *